Patent · US Active

Delivery of immune response modifier compounds

US8961477B2 · kind B2 · utility

1Cited by
118References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 25, 2004
Grant dateFeb 24, 2015
Priority date—
Expiry dateDec 1, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2037/0046
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Delivery of one or more immune response modifiers (IRMs) across a biological barrier by the use of a microneedle device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.